Major basic protein is a useful marker to distinguish eosinophilic esophagitis from IBD‐associated eosinophilia in children
Journal of Pediatric Gastroenterology and Nutrition · 2024
DOI: 10.1002/jpn3.12143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2024. Verfasst von Samantha Butzke und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Gastroenterology, Nemours Children's Health, Wilmington, Delaware, USA. Hauptthemen laut MEDLINE: Eosinophilic Esophagitis, Inflammatory Bowel Diseases, Enteritis, Eosinophilia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: None.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objectives
The incidence of eosinophilic esophagitis (EoE) is 3−5 times greater in patients with inflammatory bowel disease (IBD) compared with the general population. This study aimed to differentiate true EoE from esophageal eosinophilia in IBD patients by evaluating expression of major basic protein (MBP) and interleukin‐13 (IL‐13) in esophageal biopsies.
Methods
This retrospective study included subjects who had an esophagogastroduodenoscopy with esophageal biopsies for IBD work up or suspicion for EoE. Patients were classified into 5 groups: EoE with ≥15 eosinophils per high power field (eos/hpf), EoE‐IBD with ≥15 eos/hpf, IBD eosinophilia with 1−14 eos/hpf, IBD and control groups. Biopsies were stained with MBP and IL‐13 antibodies and the results (% staining/total tissue area), demographic, and clinical findings were compared among the groups.
Results
The median for MBP staining levels in EoE‐IBD was 3.8 (interquartile range 1.3−23), significantly lower than in EoE at 52.8 (8.3−113.2), but higher than in IBD eosinophilia at 0.2 (0−0.9; p < 0.001) and negligible in the IBD and control groups. IL‐13 expression in EoE was significantly higher only compared with IBD and controls not with EoE‐IBD or IBD eosinophilia. MBP predicted EoE with 100% sensitivity and 99% specificity while IL‐13 had 83% sensitivity and 90% specificity using cutoff point from the cohort without EoE‐IBD patients. Based on MBP cutoff point that distinguished EoE from non EoE, 56% in EoE‐IBD were MBP‐positive whereas 100% in EoE group ( p < 0.05).
Conclusions
MBP may be an excellent marker in distinguishing true EoE from eosinophilia caused by IBD. Our data implied that MBP together with endoscopic and histologic changes can assist EoE diagnosis in IBD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Gastroenterology, Nemours Children's Health, Wilmington, Delaware, USA.
- Division of Pathology, Nemours Children's Health, Wilmington, Delaware, USA.
- Nemours Biomedical Research, Nemours Children's Health, Wilmington, Delaware, USA.
Förderung
- None
Zitieren
APA
Butzke, S., Nasiri-Blomgren, S., Corao-Uribe, D., He, Z., & Molle-Rios, Z. (2024). Major basic protein is a useful marker to distinguish eosinophilic esophagitis from IBD‐associated eosinophilia in children. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.12143
Vancouver
Butzke S, Nasiri-Blomgren S, Corao-Uribe D, He Z, Molle-Rios Z. Major basic protein is a useful marker to distinguish eosinophilic esophagitis from IBD‐associated eosinophilia in children. Journal of Pediatric Gastroenterology and Nutrition. 2024. doi:10.1002/jpn3.12143
BibTeX
@article{Butzke2024,
author = {Butzke, Samantha and Nasiri-Blomgren, Shaida and Corao-Uribe, Diana and He, Zhaoping and Molle-Rios, Zarela},
title = {Major basic protein is a useful marker to distinguish eosinophilic esophagitis from IBD‐associated eosinophilia in children},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2024},
doi = {10.1002/jpn3.12143}
}
EUVIMED